Study S001150

Influence of Liraglutide, a GLP-1 Receptor Agonist, on Brown Adipose Tissue (BAT) Activity in Humans

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT02718950
Acronym: i-LAB
Study type: INTERVENTIONAL
Phase: PHASE3
Masking: NONE
Status: UNKNOWN
Enrollment: 20
Start: 2016-06
Primary completion: 2017-03
Lead sponsor: University of Campinas, Brazil
Conditions: Obesity; Type 2 Diabetes Mellitus
Interventions: DRUG:Liraglutide 3.0 mg
Results posted: FALSE
Individual participant data sharing: NO
Secondary identifiers: REGISTRY:U1111-1178-4180

Registered primary outcomes

Evaluate the effect of liraglutide administration on brown adipose tissue (BAT) activation in humans [2 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.